Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00539409 · ClinicalTrials.gov registry record · Phase 2
Effects of Pulsatile Intravenous Insulin Therapy on Metabolic Integrity in Patients With Diabetes Mellitus
A Phase 2 study, sponsored by Florida Atlantic University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 152
- Enrollment target
NCT00539409 is a Phase 2 study that was terminated before completion, run by Florida Atlantic University. The registered enrollment target is 152 participants.
The verdict
NCT00539409, a Phase 2 study, was terminated before completion, sponsored by Florida Atlantic University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 152 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if restoring normal metabolic function in patients with either type I or type II diabetes can improve the impact of the consequences of diabetic complications on the overall quality of life of diabetic patients. Patients are treated once a week with pulsatile intravenous insulin therapy mimicking normal insulin secretion. A diabetic quality of life questionnaire is completed prior to the start of the treatment and quarterly thereafter with detailed analysis performed to measure progress and outcomes
Interventions
- PROCEDURE Pulsatile Intravenous Insulin Therapy (Humulin R, Novolog)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00539409
The ClinicalTrials.gov registry entry for NCT00539409 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida Atlantic University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulsatile Intravenous Insulin Therapy (Humulin R, Novolog) is the first listed.
NCT00539409 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00539409 about?
NCT00539409 is a clinical study titled "Effects of Pulsatile Intravenous Insulin Therapy on Metabolic Integrity in Patients With Diabetes Mellitus". The purpose of this study is to determine if restoring normal metabolic function in patients with either type I or type II diabetes can improve the impact of the consequences of diabetic complications on the overall quality of life of diabetic patients. Patients are treated once a week with pulsatil...
What is the current status of trial NCT00539409?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 152 participants. The study started on 2006-11. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00539409?
The interventions under investigation include: Pulsatile Intravenous Insulin Therapy (Humulin R, Novolog) (PROCEDURE).
Who is sponsoring clinical trial NCT00539409?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.